This report provides a comprehensive analysis of current global Insomnia Treatment Drugs market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Insomnia Treatment Drugs industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

According to GRD Survey, the global Insomnia Treatment Drugs market is estimated at $ million in 2021, and projected to grow at a CAGR of % to $ million by 2028.

Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Insomnia Treatment Drugs Market Opportunties and Forecast 2022-2028 report makes a brilliant attempt to unveil key opportunities available in the global Insomnia Treatment Drugs market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

The Global Insomnia Treatment Drugs Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Insomnia Treatment Drugs industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions


Segmented by Type
Prescription Sleep Aids
Over the Counter (OTC) Sleep Aids

Segmented by Application
Hospital
Pharmacy
Others

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Takeda Pharmaceutical Company Ltd.
Sumitomo Dainippon Pharma Co., Ltd
Sanofi S.A.
Pfizer, Inc.
Pernix Therapeutics
Mylan N.V.
Merck & Co. Inc.
F.Hoffman La-Roche AG

Table of Contents

1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Insomnia Treatment Drugs Market Status and Forecast (2017-2028)
1.3.2 Global Insomnia Treatment Drugs Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Insomnia Treatment Drugs Supply by Company
2.1 Global Insomnia Treatment Drugs Sales Volume by Company
2.2 Global Insomnia Treatment Drugs Sales Value by Company
2.3 Global Insomnia Treatment Drugs Price by Company
2.4 Insomnia Treatment Drugs Production Location and Sales Area of Main Manufacturers
2.5 Trend of Concentration Rate
3 Global and Regional Insomnia Treatment Drugs Market Status by Type
3.1 Insomnia Treatment Drugs Type Introduction
3.1.1 Prescription Sleep Aids
3.1.2 Over the Counter (OTC) Sleep Aids
3.2 Global Insomnia Treatment Drugs Market by Type
3.2.1 Global Insomnia Treatment Drugs Sales Volume by Type (2017-2022)
3.2.2 Global Insomnia Treatment Drugs Sales Value by Type (2017-2022)
3.2.3 Global Insomnia Treatment Drugs Price by Type (2017-2022)
3.3 North America: by Type
3.4 Europe: by Type
3.5 Asia Pacific: by Type
3.6 Central & South America: by Type
3.7 Middle East & Africa: by Type
4 Global and Regional Insomnia Treatment Drugs Market Status by Application
4.1 Insomnia Treatment Drugs Segment by Application
4.1.1 Hospital
4.1.2 Pharmacy
4.1.3 Others
4.2 Global Insomnia Treatment Drugs Market by Application
4.2.1 Global Insomnia Treatment Drugs Sales Volume by Application (2017-2022)
4.2.2 Global Insomnia Treatment Drugs Sales Value by Application (2017-2022)
4.2.3 Global Insomnia Treatment Drugs Price by Application (2017-2022)
4.3 North America: by Application
4.4 Europe: by Application
4.5 Asia Pacific: by Application
4.6 Central & South America: by Application
4.7 Middle East & Africa: by Application
5 Global Insomnia Treatment Drugs Market Status by Region
5.1 Global Insomnia Treatment Drugs Market by Region
5.1.1 Global Insomnia Treatment Drugs Sales Volume by Region
5.1.2 Global Insomnia Treatment Drugs Sales Value by Region
5.2 North America Insomnia Treatment Drugs Market Status
5.3 Europe Insomnia Treatment Drugs Market Status
5.4 Asia Pacific Insomnia Treatment Drugs Market Status
5.5 Central & South America Insomnia Treatment Drugs Market Status
5.6 Middle East & Africa Insomnia Treatment Drugs Market Status
6 North America Insomnia Treatment Drugs Market Status
6.1 North America Insomnia Treatment Drugs Market by Country
6.1.1 North America Insomnia Treatment Drugs Sales Volume by Country (2017-2022)
6.1.2 North America Insomnia Treatment Drugs Sales Value by Country (2017-2022)
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Insomnia Treatment Drugs Market Status
7.1 Europe Insomnia Treatment Drugs Market by Country
7.1.1 Europe Insomnia Treatment Drugs Sales Volume by Country (2017-2022)
7.1.2 Europe Insomnia Treatment Drugs Sales Value by Country (2017-2022)
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Insomnia Treatment Drugs Market Status
8.1 Asia Pacific Insomnia Treatment Drugs Market by Country
8.1.1 Asia Pacific Insomnia Treatment Drugs Sales Volume by Country (2017-2022)
8.1.2 Asia Pacific Insomnia Treatment Drugs Sales Value by Country (2017-2022)
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Insomnia Treatment Drugs Market Status
9.1 Central & South America Insomnia Treatment Drugs Market by Country
9.1.1 Central & South America Insomnia Treatment Drugs Sales Volume by Country (2017-2022)
9.1.2 Central & South America Insomnia Treatment Drugs Sales Value by Country (2017-2022)
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Insomnia Treatment Drugs Market Status
10.1 Middle East & Africa Insomnia Treatment Drugs Market by Country
10.1.1 Middle East & Africa Insomnia Treatment Drugs Sales Volume by Country (2017-2022)
10.1.2 Middle East & Africa Insomnia Treatment Drugs Sales Value by Country (2017-2022)
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Supply Chain and Manufacturing Cost Analysis
11.1 Supply Chain Analysis
11.2 Production Process Chart Analysis
11.3 Raw Materials and Key Suppliers Analysis
11.3.1 Raw Materials Introduction
11.3.2 Raw Materials Key Suppliers List
11.4 Insomnia Treatment Drugs Manufacturing Cost Analysis
11.5 Insomnia Treatment Drugs Sales Channel and Distributors Analysis
11.5.1 Insomnia Treatment Drugs Sales Channel
11.5.2 Insomnia Treatment Drugs Distributors
11.6 Insomnia Treatment Drugs Downstream Major Buyers
12 Global Insomnia Treatment Drugs Market Forecast by Type and by Application
12.1 Global Insomnia Treatment Drugs Sales Volume and Sales Value Forecast (2023-2028)
12.2 Global Insomnia Treatment Drugs Forecast by Type
12.2.1 Global Insomnia Treatment Drugs Sales Volume Forecast by Type
12.2.2 Global Insomnia Treatment Drugs Sales Value Forecast by Type
12.2.3 Global Insomnia Treatment Drugs Price Forecast by Type
12.3 Global Insomnia Treatment Drugs Forecast by Application
12.3.1 Global Insomnia Treatment Drugs Sales Volume Forecast by Application
12.3.2 Global Insomnia Treatment Drugs Sales Value Forecast by Application
12.3.3 Global Insomnia Treatment Drugs Price Forecast by Application
13 Global Insomnia Treatment Drugs Market Forecast by Region/Country
13.1 Global Insomnia Treatment Drugs Market Forecast by Region (2023-2028)
13.1.1 Global Insomnia Treatment Drugs Sales Volume Forecast by Region (2023-2028)
13.1.2 Global Insomnia Treatment Drugs Sales Value Forecast by Region (2023-2028)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 Vanda Pharmaceuticals, Inc.
14.1.1 Company Information
14.1.2 Insomnia Treatment Drugs Product Introduction
14.1.3 Vanda Pharmaceuticals, Inc. Insomnia Treatment Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
14.1.4 SWOT Analysis
14.2 Teva Pharmaceutical Industries Ltd.
14.2.1 Company Information
14.2.2 Insomnia Treatment Drugs Product Introduction
14.2.3 Teva Pharmaceutical Industries Ltd. Insomnia Treatment Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
14.2.4 SWOT Analysis
14.3 Takeda Pharmaceutical Company Ltd.
14.3.1 Company Information
14.3.2 Insomnia Treatment Drugs Product Introduction
14.3.3 Takeda Pharmaceutical Company Ltd. Insomnia Treatment Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
14.3.4 SWOT Analysis
14.4 Sumitomo Dainippon Pharma Co., Ltd
14.4.1 Company Information
14.4.2 Insomnia Treatment Drugs Product Introduction
14.4.3 Sumitomo Dainippon Pharma Co., Ltd Insomnia Treatment Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
14.4.4 SWOT Analysis
14.5 Sanofi S.A.
14.5.1 Company Information
14.5.2 Insomnia Treatment Drugs Product Introduction
14.5.3 Sanofi S.A. Insomnia Treatment Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
14.5.4 SWOT Analysis
14.6 Pfizer, Inc.
14.6.1 Company Information
14.6.2 Insomnia Treatment Drugs Product Introduction
14.6.3 Pfizer, Inc. Insomnia Treatment Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
14.6.4 SWOT Analysis
14.7 Pernix Therapeutics
14.7.1 Company Information
14.7.2 Insomnia Treatment Drugs Product Introduction
14.7.3 Pernix Therapeutics Insomnia Treatment Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
14.7.4 SWOT Analysis
14.8 Mylan N.V.
14.8.1 Company Information
14.8.2 Insomnia Treatment Drugs Product Introduction
14.8.3 Mylan N.V. Insomnia Treatment Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
14.8.4 SWOT Analysis
14.9 Merck & Co. Inc.
14.9.1 Company Information
14.9.2 Insomnia Treatment Drugs Product Introduction
14.9.3 Merck & Co. Inc. Insomnia Treatment Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
14.9.4 SWOT Analysis
14.10 F.Hoffman La-Roche AG
14.10.1 Company Information
14.10.2 Insomnia Treatment Drugs Product Introduction
14.10.3 F.Hoffman La-Roche AG Insomnia Treatment Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
14.10.4 SWOT Analysis
15 Conclusion
16 Methodology